These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29916535)

  • 1. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
    Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
    Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
    Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
    Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2-GPI: a novel factor in the development of hepatocellular carcinoma.
    Jing X; Piao YF; Liu Y; Gao PJ
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1671-80. PubMed ID: 20204408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen impairs TLR4 signaling by upregulating A20 expression in monocytes.
    Wang C; Huang C; Li Y; Bai J; Zhao K; Fang Z; Chen J
    Microbiol Spectr; 2024 Oct; 12(10):e0090924. PubMed ID: 39248482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor κB in Liver Cancer Cells.
    Jing X; Tian ZB; Gao PJ; Han NJ; Xu YH; Zhang H; Ding XL; Wang XW; Man X; Zhang CP
    Clin Lab; 2015; 61(9):1239-45. PubMed ID: 26554243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex.
    Wang T; Ouyang H; Zhou H; Xia L; Wang X; Wang T
    Int J Mol Med; 2018 Oct; 42(4):1955-1966. PubMed ID: 30085340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-β
    Zha C; Zhang W; Gao F; Xu J; Jia R; Cai J; Liu Y
    Neuropharmacology; 2018 Aug; 138():140-150. PubMed ID: 29883691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OxLDL/β2GPI/anti‑β2GPI Ab complex induces inflammatory activation via the TLR4/NF‑κB pathway in HUVECs.
    Zhang G; Cai Q; Zhou H; He C; Chen Y; Zhang P; Wang T; Xu L; Yan J
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro.
    Zhang R; Real CI; Liu C; Baba HA; Gerken G; Lu M; Broering R
    Int J Cancer; 2017 Jul; 141(2):354-363. PubMed ID: 28419472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells.
    Liu Y; Gao P
    Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
    Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
    [No Abstract]   [Full Text] [Related]  

  • 18. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway
    Deng F; Xu G; Cheng Z; Huang Y; Ma C; Luo C; Yu C; Wang J; Xu X; Liu S; Zhu Y
    Front Immunol; 2021; 12():618196. PubMed ID: 33717111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
    Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.